Advertisement

Topics

CLEO: 2014 Company Profile

04:30 EDT 26th September 2018 | BioPortfolio

With a distinguished history as the industry's leading event on laser science, the Conference on Lasers and Electro-Optics (CLEO) is the premier international forum for scientific and technical optics, uniting the fields of lasers and opto-electronics by bringing together all aspects of laser technology, from basic research to industry applications. CLEO: Expo showcases the latest products and applications from more than 300 participating companies from around the world, providing hands-on demonstrations of the latest market innovations and applications. The Expo also offers valuable on-floor programming, including Market Focus and the Technology Transfer program.


News Articles [180 Associated News Articles listed on BioPortfolio]

Parenthood Transition Startup Cleo Raises $10.5 Million Series A Round

The latest funding will go toward expanding Cleo's parent support service that helps employees welcome home a new baby and employers welcome parents back to work.

The Obesity Paradox in RCC

Although being overweight does increase the risks for renal cell cancer (RCC), a recent study from Dr. Albiges and colleagues from ASCO 2014 shows that overweight or obese patients with kidney cancer ...

What Is Non-Clear Cell Kidney Cancer?

Among kidney cancer patients, the sub-type “non-clear cell” is the least common. As a result, not much research has been conducted on it.Related Posts:No C

How is the Heng Criteria Applied to Kidney Cancer Patients?

Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer patients to determine their prognoses.Related Posts:Evaluating Biomarkers in Kidney Cancer August...

Evaluating Biomarkers in Kidney Cancer

Biomarkers can give clues to many predictive and prognostic issues, like how a patient may respond to a drug or if a patient’s cancer is likely to recur. Dr. Daniel Heng discusses what researche...

Can Systemic Therapy Wait?

Patients with metastatic renal cell carcinoma (mRCC) with an indolent growth pattern may be able to put off systemic therapy and be observed for a period of time instead. Dr. Rini and colleagues prese...

No Clear Answer for Non-Clear Cell Kidney Cancer

Drugs in early stage clinical trials seem to show benefit for non-clear cell kidney cancer, but more trials must take place and patients are desperately needed to enroll in them.Related Posts:

NAS Infants with Medicaid Cost Hospitals $460+ Million in 2014 (CME/CE)

(MedPage Today) -- Incidence of neonatal abstinence syndrome also increased five-fold from 2004 to 2014

Drugs and Medications [0 Results]

None

PubMed Articles [466 Associated PubMed Articles listed on BioPortfolio]

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.

To determine antibiotic susceptibility in isolates of Streptococcus pneumoniae and Haemophilus influenzae collected in 2014-16 from Russia.

Trends in Socioeconomic Disparities in Obesity Prevalence among Low-Income Children Aged 2-4 Years in Los Angeles County, 2003-2014.

Obesity prevalence among low-income preschool-aged children in the United States decreased between 2010 and 2014. However, this decreasing trend may be varied across socioeconomic subgroups. This stud...

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece.

To determine antimicrobial susceptibility in isolates of Streptococcus pneumoniae and Haemophilus influenzae collected in 2014-16 from patients with community-acquired respiratory tract infections in ...

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic.

To determine the antibiotic susceptibility of isolates of Streptococcus pneumoniae and Haemophilus influenzae collected in 2014-16 from patients with community-acquired respiratory infections in the C...

Lack of Change in Perinatal Mortality in the United States, 2014-2016.

Perinatal mortality (late fetal death at 28 weeks or more and early neonatal death under age 7 days) can be an indicator of the quality of health care before, during, and after delivery (1,2). The U.S...

Clinical Trials [438 Associated Clinical Trials listed on BioPortfolio]

A Phase I, Three-part Study to Determine the Maximum Tolerated Dose/Recommended Dose, Compare Bioavailability in the Fed and Fasted States, and Evaluate Safety and Tolerability of ORH-2014 in Subjects With Advanced Hematological Disorders

Part 1 will be conducted as an open-label, non-randomized, non-placebo-controlled dose escalation study using pre-specified doses. Subjects with the following advanced hematological disord...

Fusarium Keratitits in Spain 2012 to 2014

The aim of this study was to describe the clinical-epidemiological characteristics of a series of cases of fungal keratitis associated with Fusarium spp., In Spain during the years 2012 to...

Development and Impact of Multivariate Model-based Strategy to Target High-risk Patients of Postoperative Complication

The objective is therefore to create a risk score for ADEs in an orthopedic and traumatological surgery department. The study is an prospective, observational, cohort trial. A first step ...

Tramadol in Penial Block Does it Improve Efficiency of Postoperative Analgesia in Circumcision

After the consent of the local ethics committee and informed consent of the parents, we conducted a prospective randomized, double-blind study, from 30 June 2014 to 31 December 2014, inclu...

Deep Brain Stimulation in HUCH Region Between 2006 and 2014

This study reviews the outcome of deep brain stimulation treated patients in Helsinki and Uusimaa University Hospital between 2006 and 2014. The aim of the study is to investigate the outc...

Companies [244 Associated Companies listed on BioPortfolio]

CLEO: 2014

With a distinguished history as the industry's leading event on laser science, the Conference on Lasers and Electro-Optics (CLEO) is the premier international forum for scientific...

CLEO: 2013

With a distinguished history as the industry's leading event on laser science, the Conference on Lasers and Electro-Optics (CLEO) is where laser technology was first introduced. C...

CLEO: 2012

With a distinguished history as the industry’s leading event on laser science, the Conference on Lasers and Electro-Optics (CLEO) is where laser technology was first introduc...

CLEO: 2011

What: Conference on Lasers and Electro-Optics (CLEO: 2011)

CLEO 2015

With a distinguished history as the industry's leading event on laser science, the Conference on Lasers and Electro-Optics (CLEO) is the premier international forum for scientific...

More Information about "CLEO: 2014" on BioPortfolio

We have published hundreds of CLEO: 2014 news stories on BioPortfolio along with dozens of CLEO: 2014 Clinical Trials and PubMed Articles about CLEO: 2014 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CLEO: 2014 Companies in our database. You can also find out about relevant CLEO: 2014 Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record